UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer

Clinical cancer research, 2017-01, Vol.23 (2), p.370-378

2017

Volltextzugriff (PDF)

PD-L1 Expression Scoring: Noninterchangeable, Noninterpretable, Neither, or Both

JNCI : Journal of the National Cancer Institute, 2021-11, Vol.113 (12), p.1613-1614

2021

Volltextzugriff (PDF)

Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes

Cancer research (Chicago, Ill.), 2021-08, Vol.81 (16), p.4346-4359

2021

Volltextzugriff (PDF)

A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1

JAMA oncology, 2017-02, Vol.3 (2), p.256

2017

Volltextzugriff (PDF)

BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome

Breast cancer research : BCR, 2013-07, Vol.15 (4), p.R52-R52, Article R52

2013

Volltextzugriff (PDF)

Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer

PloS one, 2023-03, Vol.18 (3), p.e0282512-e0282512

2023

Volltextzugriff (PDF)

cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?

Expert opinion on therapeutic targets, 2014-09, Vol.18 (9), p.999-1009

2014

Volltextzugriff (PDF)

Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A

Investigational new drugs, 2020-10, Vol.38 (5), p.1365-1372

2020

Volltextzugriff (PDF)

Bile acid distributions, sex-specificity, and prognosis in colorectal cancer

Biology of sex differences, 2022-10, Vol.13 (1), p.61-13, Article 61

2022

Volltextzugriff (PDF)

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells

Cancers, 2019-04, Vol.11 (4), p.548

2019

Volltextzugriff (PDF)

Nuclear IRF-1 expression as a mechanism to assess "Capability" to express PD-L1 and response to PD-1 therapy in metastatic melanoma

Journal for immunotherapy of cancer, 2017-03, Vol.5 (1), p.25, Article 25

2017

Volltextzugriff (PDF)

Measurement of spatial and antibody-based PD-L1 heterogeneity in non-small cell lung cancer

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.9040-9040

2016

Volltextzugriff (PDF)

PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast Cancer

Clinical cancer research, 2020-10, Vol.26 (20), p.5456-5461

2020

Volltextzugriff (PDF)

B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes

Clinical cancer research, 2017-09, Vol.23 (17), p.5202-5209

2017

Volltextzugriff (PDF)

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Laboratory investigation, 2022-10, Vol.102 (10), p.1101-1108

2022

Volltextzugriff (PDF)

Immune Inhibitory Molecule PD-1 Homolog (VISTA) Colocalizes with CD11b Myeloid Cells in Melanoma and Is Associated with Poor Outcomes

Journal of investigative dermatology, 2024-01, Vol.144 (1), p.106-115.e4

2024

Volltextzugriff (PDF)

Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer

Clinical cancer research, 2022-03, Vol.28 (5), p.984-992

2022

Volltextzugriff (PDF)

PD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus

Science translational medicine, 2019-12, Vol.11 (522)

2019

Volltextzugriff (PDF)

Abstract P4-10-14: Quantitative assessment of PD-L1 protein expression on macrophages and tumor cells as predictive markers of response to neoadjuvant durvalumab and chemotherapy in triple negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P4-P4-10-14

2020

Volltextzugriff (PDF)

Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarray

Laboratory investigation, 2020-01, Vol.100 (1), p.4-15

2020

Volltextzugriff (PDF)

Preclinical evaluation of Insulin-like growth factor receptor 1 as a therapeutic targets in triple negative breast cancer

PloS one, 2023-03, Vol.18 (3), p.e0282512

2023

Volltextzugriff (PDF)

Preclinical evaluation of Insulin-like growth factor receptor 1

PloS one, 2023-03, Vol.18 (3), p.e0282512

2023

Volltextzugriff (PDF)

Abstract PO5-13-11: Quantitative Assessment of HER2 Expression in Intraductal Neoplasms of the Breast

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO5-13-11-PO5-13-11

2024

Volltextzugriff (PDF)

Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas

Journal of neuropathology and experimental neurology, 2021-02, Vol.80 (2), p.150-159

2021

Volltextzugriff (PDF)

Assessment of the Impact of Alternative Fixatives on HER2 Detection in Breast Cancer and Gastric Cancer Tumor Specimens

Applied immunohistochemistry & molecular morphology, 2023-05, Vol.31 (5), p.339-345

2023

Volltextzugriff (PDF)

1 – 25 von 30

Suche als RSS-Feed

Aktive Filter

Zeitschrift / SerieModern Pathology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(30)

Sprache

Englisch
(30)
Japanisch
(7)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Differential Expression and Significance of PD-L1, IDO-1, and B7-H4 in Human Lung Cancer

PD-L1 Expression Scoring: Noninterchangeable, Noninterpretable, Neither, or Both

Targeting Pyruvate Kinase M2 Phosphorylation Reverses Aggressive Cancer Phenotypes

A Quantitative Comparison of Antibodies to Programmed Cell Death 1 Ligand 1

BreastMark: an integrated approach to mining publicly available transcriptomic datasets relating to breast cancer outcome

Preclinical evaluation of Insulin-like growth factor receptor 1 (IGF1R) and Insulin Receptor (IR) as a therapeutic targets in triple negative breast cancer

cMET in triple-negative breast cancer: is it a therapeutic target for this subset of breast cancer patients?

Targeting c-Met in triple negative breast cancer: preclinical studies using the c-Met inhibitor, Cpd A

Bile acid distributions, sex-specificity, and prognosis in colorectal cancer

Dasatinib Treatment Increases Sensitivity to c-Met Inhibition in Triple-Negative Breast Cancer Cells

Nuclear IRF-1 expression as a mechanism to assess "Capability" to express PD-L1 and response to PD-1 therapy in metastatic melanoma

Measurement of spatial and antibody-based PD-L1 heterogeneity in non-small cell lung cancer

PD-L1 Protein Expression on Both Tumor Cells and Macrophages are Associated with Response to Neoadjuvant Durvalumab with Chemotherapy in Triple-negative Breast Cancer

B7-H3 Expression in NSCLC and Its Association with B7-H4, PD-L1 and Tumor-Infiltrating Lymphocytes

Quantitative measurement of HER2 expression to subclassify ERBB2 unamplified breast cancer

Immune Inhibitory Molecule PD-1 Homolog (VISTA) Colocalizes with CD11b Myeloid Cells in Melanoma and Is Associated with Poor Outcomes

Multi-scale Pan-cancer Integrative Analyses Identify the STAT3-VSIR Axis as a Key Immunosuppressive Mechanism in Head and Neck Cancer

PD-1H (VISTA)–mediated suppression of autoimmunity in systemic and cutaneous lupus erythematosus

Abstract P4-10-14: Quantitative assessment of PD-L1 protein expression on macrophages and tumor cells as predictive markers of response to neoadjuvant durvalumab and chemotherapy in triple negative breast cancer (TNBC)

Quantitative assessment of PD-L1 as an analyte in immunohistochemistry diagnostic assays using a standardized cell line tissue microarray

Preclinical evaluation of Insulin-like growth factor receptor 1 as a therapeutic targets in triple negative breast cancer

Preclinical evaluation of Insulin-like growth factor receptor 1

Abstract PO5-13-11: Quantitative Assessment of HER2 Expression in Intraductal Neoplasms of the Breast

Spatially Resolved and Quantitative Analysis of the Immunological Landscape in Human Meningiomas

Assessment of the Impact of Alternative Fixatives on HER2 Detection in Breast Cancer and Gastric Cancer Tumor Specimens

Aktive Filter

Suchergebnisse filtern